Your browser is no longer supported. Please, upgrade your browser.
Settings
REPH Recro Pharma, Inc. daily Stock Chart
REPH [NASD]
Recro Pharma, Inc.
Index- P/E- EPS (ttm)-2.76 Insider Own0.10% Shs Outstand21.48M Perf Week-6.14%
Market Cap141.12M Forward P/E- EPS next Y-2.91 Insider Trans-89.75% Shs Float20.17M Perf Month-9.13%
Income-54.60M PEG- EPS next Q-0.74 Inst Own67.40% Short Float2.55% Perf Quarter6.31%
Sales78.60M P/S1.80 EPS this Y21.50% Inst Trans-2.60% Short Ratio2.58 Perf Half Y-48.39%
Book/sh0.65 P/B10.11 EPS next Y-9.80% ROA-34.70% Target Price14.80 Perf Year-25.09%
Cash/sh1.72 P/C3.81 EPS next 5Y- ROE-273.40% 52W Range4.78 - 13.05 Perf YTD-28.97%
Dividend- P/FCF- EPS past 5Y-43.60% ROI-37.10% 52W High-49.66% Beta-0.51
Dividend %- Quick Ratio1.20 Sales past 5Y- Gross Margin47.30% 52W Low37.45% ATR0.37
Employees255 Current Ratio1.40 Sales Q/Q7.00% Oper. Margin-67.10% RSI (14)43.11 Volatility5.61% 5.68%
OptionableYes Debt/Eq0.00 EPS Q/Q-34.70% Profit Margin-79.50% Rel Volume0.52 Prev Close6.57
ShortableYes LT Debt/Eq4.05 EarningsNov 07 BMO Payout- Avg Volume198.77K Price6.57
Recom1.60 SMA20-3.44% SMA50-7.34% SMA200-16.54% Volume0 Change0.00%
Feb-14-18Initiated Oppenheimer Outperform $19
Dec-19-16Initiated Piper Jaffray Overweight $12
Nov-14-16Initiated Aegis Capital Buy $21
Oct-03-16Resumed Brean Capital Buy
Sep-16-16Initiated ROTH Capital Buy
Nov-24-15Resumed H.C. Wainwright Buy $14
Sep-02-15Initiated H.C. Wainwright Buy $19
Jun-18-15Reiterated Brean Capital Buy $26 → $28
Apr-14-15Reiterated MLV & Co Buy $12 → $22
Jun-12-14Initiated Aegis Capital Buy $40
Mar-20-14Initiated Brean Capital Buy $26
Nov-18-18 09:51PM  Edited Transcript of REPH earnings conference call or presentation 7-Nov-18 1:00pm GMT Thomson Reuters StreetEvents
Nov-16-18 08:20AM  Detailed Research: Economic Perspectives on StarTek, Plantronics, Akoustis Technologies, Genie Energy, Recro Pharma, and BIO-key International What Drives Growth in Today's Competitive Landscape GlobeNewswire
Nov-14-18 07:00AM  Recro Pharma Announces Publication of Phase II IV Meloxicam Abdominal Hysterectomy Data in Anesthesia & Analgesia GlobeNewswire
Nov-08-18 07:00AM  Recro Pharma to Participate in Upcoming Investor Conferences GlobeNewswire
Nov-07-18 11:00AM  Recro Pharma (REPH) Reports Q3 Loss, Tops Revenue Estimates Zacks
10:44AM  Recro Pharma: 3Q Earnings Snapshot Associated Press
07:00AM  Recro Pharma Reports Third Quarter 2018 Financial Results Raising Guidance for CDMO business for 2018 GlobeNewswire
Oct-31-18 07:00AM  Recro Pharma to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018 GlobeNewswire
Oct-09-18 04:19PM  FDA Sets Action Date for Recro's Pain Management Candidate Zacks
Oct-08-18 12:00PM  Take two: Recro tries for second time to get FDA approval for its non-opioid pain medicine American City Business Journals
07:00AM  Recro Pharma Announces PDUFA Date for IV Meloxicam GlobeNewswire
Oct-01-18 07:00AM  Recro Announces Expansion of CDMO Service Capabilities GlobeNewswire
Sep-10-18 07:00AM  Recro Pharma to Participate in Upcoming Investor Conferences GlobeNewswire
Sep-05-18 07:00AM  Recro Pharma to Present IV Meloxicam Data at PAINWeek® 2018 GlobeNewswire +11.77%
Sep-04-18 10:50AM  Recro Pharma to resubmit application for non-opioid pain medicine American City Business Journals +26.49%
09:30AM  3 Stocks to Watch As The Healthcare Sector Heats Up ACCESSWIRE
07:00AM  Recro Pharma Provides Regulatory Update for IV Meloxicam GlobeNewswire
Aug-20-18 09:46PM  Edited Transcript of REPH earnings conference call or presentation 7-Aug-18 12:00pm GMT Thomson Reuters StreetEvents
Aug-07-18 10:40AM  Recro Pharma (REPH) Reports Q2 Loss, Tops Revenue Estimates Zacks
09:33AM  Recro Pharma: 2Q Earnings Snapshot Associated Press
07:00AM  Recro Pharma Reports Second Quarter 2018 Financial Results GlobeNewswire
06:00AM  Recro Pharma, Inc. to Host Earnings Call ACCESSWIRE
Aug-06-18 03:39PM  Recro Pharma Q2 Earnings Preview Benzinga
Jul-31-18 07:00AM  Recro Pharma to Report Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 7, 2018 GlobeNewswire
Jul-30-18 11:19AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TAL, QCOM, REVG, FLKS and REPH GlobeNewswire
10:42AM  FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $50K of Class Action Against Recro Pharma, Inc. (REPH) & Lead Plaintiff Deadline: July 30, 2018 ACCESSWIRE
Jul-29-18 11:00AM  SHAREHOLDER ALERT: TAL ORA REVG FPI NWL PCG REPH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jul-27-18 08:55PM  Glancy Prongay & Murray LLP Reminds Investors of Lead Plaintiff Deadline in the Class Action Lawsuit Against Recro Pharma, Inc. (REPH) GlobeNewswire
02:41PM  CLASS ACTION UPDATE for ORA and REPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:55PM  3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
10:38AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $50K of Class Action Against Recro Pharma, Inc. (REPH) & Lead Plaintiff Deadline: July 30, 2018 ACCESSWIRE
Jul-26-18 03:13PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MRCY, REVG and REPH GlobeNewswire
01:27PM  MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Jul-25-18 04:45PM  CLASS ACTION UPDATE for FIZZ, ACAD and REPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
04:40PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Recro Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - REPH ACCESSWIRE
02:10PM  5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Reminds Investors with Losses to Contact the Firm ACCESSWIRE
11:57AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TAL, ANW, DB, FIZZ and REPH GlobeNewswire
10:37AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Recro Pharma, Inc. (REPH) & Lead Plaintiff Deadline - July 30, 2018 ACCESSWIRE
Jul-24-18 04:00PM  CLASS ACTION UPDATE for QCOM, FLR, FPI and REPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
01:50PM  JULY 30 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
11:00AM  SHAREHOLDER ALERT: ATEN ANW DB QCOM FPI FIZZ SBGL ACAD FLR REPH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jul-23-18 06:43PM  The Law Offices of Howard G. Smith Reminds Investors of July 30th Deadline in the Class Action Lawsuit Against Recro Pharma, Inc. (REPH) Business Wire
02:30PM  DEADLINE ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:57PM  CLASS ACTION UPDATE for ATEN, FLR and REPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
01:22PM  Important Stockholder Deadline Alert in Class Action Lawsuit Filed Against Recro Pharma, Inc. by Kaskela Law LLC GlobeNewswire
12:35PM  NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Recro Pharma, Inc.- REPH ACCESSWIRE
12:15PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ORA, REPH, FLR, FIZZ, NWL and PCG GlobeNewswire
10:24AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Recro Pharma, Inc. (REPH) & Lead Plaintiff Deadline - July 30, 2018 ACCESSWIRE
Jul-22-18 05:20PM  CLASS ACTION UPDATE for QCOM, REPH and PCG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Jul-20-18 05:10PM  CLASS ACTION UPDATE for COOL, REPH and SBGL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
02:30PM  DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jul-19-18 01:00PM  SHAREHOLDER ALERT MFGP ATEN REPH DB QCOM TAL NWL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire +5.15%
10:30AM  REPH EQUITY NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Recro Pharma, Inc.; Upcoming Deadline- REPH PR Newswire
07:05AM  Free Technical Reports on Portola Pharma and Three Additional Biotech Equities ACCESSWIRE
Jul-18-18 04:08PM  CLASS ACTION UPDATE for MFGP REPH and HAIR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
03:25PM  INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
02:47PM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of REPH, ANW, DB and QCOM GlobeNewswire
02:30PM  Recro Pharma, Inc. Alert: Pawar Reminds of Important July 30, 2018 Lead Plaintiff Deadline in Class Action - REPH ACCESSWIRE
01:14PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Recro Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline REPH GlobeNewswire
Jul-17-18 11:14AM  SHAREHOLDER ALERT PPG ATEN REPH REVG UNM HAIR GOGO COOL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jul-16-18 05:35PM  DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:11PM  CLASS ACTION UPDATE for PPG and REPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:18AM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Recro Pharma, Inc. (REPH) & Lead Plaintiff Deadline July 30, 2018 ACCESSWIRE
Jul-15-18 12:00AM  SHAREHOLDER ALERT PRTA SYMC PPG MFGP FLR ATEN REPH DB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jul-14-18 08:43AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Recro Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - REPH ACCESSWIRE
Jul-13-18 12:53PM  SHAREHOLDER ALERT HAIR GOGO COOL MD GLCNF GLNCY ATEN REPH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jul-12-18 04:04PM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SYMC, MFGP, FLR, REPH, and ORA GlobeNewswire
03:20PM  DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
02:30PM  SHAREHOLDER NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Recro Pharma, Inc. - REPH ACCESSWIRE
01:48PM  SHAREHOLDER ALERT ATEN REPH REVG SBGL MRCY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jul-11-18 07:44PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Recro Pharma, Inc. Investors Business Wire
07:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Recro Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - REPH ACCESSWIRE
02:12PM  CLASS ACTION UPDATE for REVG and REPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Recro Pharma, Inc. (REPH) & Lead Plaintiff Deadline July 30, 2018 GlobeNewswire
Jul-09-18 06:06PM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PPG, MFGP, REPH, REVG and PCG GlobeNewswire
04:20PM  IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
03:18PM  SHAREHOLDER ALERT PPG MFGP FLR ATEN REPH DB ANW REVG: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jul-07-18 04:39PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Recro Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - REPH ACCESSWIRE
Jul-06-18 07:15PM  DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
04:47PM  REPH LOSS ALERT: Rosen Law Firm Reminds Recro Pharma, Inc. Investors of Important July Deadline in Suit REPH GlobeNewswire
10:51AM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ESPR, ORA, MFGP, FLR, and REPH GlobeNewswire
Jul-05-18 03:00PM  REPH NOTICE: Pawar Law Group Announces Important July 30, 2018 Lead Plaintiff Deadline in Class Action - REPH ACCESSWIRE
01:00PM  CLASS ACTION UPDATE for FLR, REPH, DB and REVG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:39AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Recro Pharma, Inc. (REPH) & Lead Plaintiff Deadline - July 30, 2018 ACCESSWIRE
Jul-04-18 08:15AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Recro Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline REPH Business Wire
Jul-03-18 01:00PM  CLASS ACTION UPDATE for PRTA, MFGP, and REPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Jul-02-18 01:03PM  SHAREHOLDER ALERT LC ESPR INWK FLEX KLIC SYMC MFGP FLR REPH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Jun-30-18 07:14AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Recro Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - REPH ACCESSWIRE
Jun-29-18 08:00PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
07:41PM  SHAREHOLDER DEADLINE ALERT: INWK FLEX SYMC PPG FLR REPH ORA NWL GOGO; Johnson Fistel Reminds Investors of Important Class Action Deadlines PR Newswire
05:45PM  RECRO LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Recro Pharma, Inc. To Contact The Firm GlobeNewswire
Jun-28-18 03:00PM  SHAREHOLDER ALERT GOGO INWK FLEX SYMC REPH ORA TAL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
01:46PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Recro Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline REPH Business Wire
Jun-27-18 02:52PM  UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KLIC, REPH, ANW, and PCG GlobeNewswire -6.00%
10:52AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Recro Pharma, Inc. (REPH) & Lead Plaintiff Deadline - July 30, 2018 ACCESSWIRE
Jun-26-18 02:27PM  SHAREHOLDER ALERT FLR REPH TAL HAIR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:20AM  Recro Pharma ALERT NOTICE: Pawar Announces Important July 30, 2018 Lead Plaintiff Deadline in Class Action - REPH ACCESSWIRE
07:00AM  Recro Pharma Announces Publication of Phase III IV Meloxicam Abdominoplasty Data in Plastic and Reconstructive Surgery Global Open Journal GlobeNewswire
Jun-25-18 03:10PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Recro Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
02:20PM  EQUITY ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Recro Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 30, 2018 - REPH ACCESSWIRE
Recro Pharma, Inc., a specialty pharmaceutical company, engages in developing non-opioid products for the treatment of acute pain primarily in the United States. The company's lead product candidate includes injectable meloxicam, which completed pivotal phase III clinical trials for the treatment of post-operative pain. It also develops Dex-IN, an intranasal formulation of dexmedetomidine for treating post-operative pain and peri-procedural pain; two novel neuromuscular blocking agents and a related proprietary chemical reversal agent; and Fadolmidine for use in as human therapeutic. The company also provides contract development and manufacturing services. Recro Pharma, Inc. has a license agreement with Orion Corporation for the development and commercialization of Dexmedetomidine. It focuses on offering its products for hospitals and related markets. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was founded in 2007 and is based in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Broadfin Healthcare Master Fun10% OwnerMay 24Sale5.81188,0001,093,1822,048,025May 24 05:02 PM
Broadfin Healthcare Master Fun10% OwnerMar 13Sale10.07200,0002,014,0002,236,025Mar 15 04:11 PM
Berelowitz MichaelDirectorMar 09Option Exercise2.477,50018,5257,500Mar 13 04:15 PM
Berelowitz MichaelDirectorMar 09Sale10.457,50078,3470Mar 13 04:15 PM
SCP Vitalife Partners (Israel)10% OwnerJan 04Sale8.841,57913,956726,055Jan 08 04:21 PM
SCP Vitalife Partners II LP10% OwnerJan 04Sale8.844,73241,8222,172,900Jan 08 04:20 PM
SCP Vitalife Partners (Israel)10% OwnerJan 03Sale8.736,63557,943727,634Jan 04 07:45 PM
SCP Vitalife Partners II LP10% OwnerJan 03Sale8.7319,863173,4642,177,632Jan 04 07:45 PM
SCP Vitalife Partners (Israel)10% OwnerJan 02Sale9.046,32957,195734,269Jan 04 07:45 PM
SCP Vitalife Partners II LP10% OwnerJan 02Sale9.0418,947171,2242,197,495Jan 04 07:45 PM
SCP Vitalife Partners (Israel)10% OwnerDec 29Sale9.194,11037,791740,598Jan 02 04:07 PM
SCP Vitalife Partners II LP10% OwnerDec 29Sale9.1912,305113,1422,216,442Jan 02 04:06 PM
SCP Vitalife Partners (Israel)10% OwnerDec 28Sale9.441,98018,690744,708Jan 02 04:07 PM
SCP Vitalife Partners II LP10% OwnerDec 28Sale9.445,92655,9382,228,747Jan 02 04:06 PM
SCP Vitalife Partners (Israel)10% OwnerDec 27Sale9.542,80326,737746,688Dec 28 04:21 PM
SCP Vitalife Partners II LP10% OwnerDec 27Sale9.548,39180,0402,234,673Dec 28 04:21 PM
SCP Vitalife Partners (Israel)10% OwnerDec 26Sale9.591,60215,364749,491Dec 28 04:21 PM
SCP Vitalife Partners II LP10% OwnerDec 26Sale9.594,79846,0162,243,064Dec 28 04:21 PM
Broadfin Healthcare Master Fun10% OwnerDec 21Sale9.8151,000500,2402,436,025Dec 22 04:05 PM
Broadfin Healthcare Master Fun10% OwnerDec 20Sale10.0025,000250,0002,487,025Dec 22 04:05 PM
Broadfin Healthcare Master Fun10% OwnerDec 13Sale9.8218,137178,1392,512,025Dec 14 04:12 PM
Broadfin Healthcare Master Fun10% OwnerDec 12Sale9.8775,100740,9892,530,162Dec 14 04:12 PM
Broadfin Healthcare Master Fun10% OwnerDec 05Sale10.00100,0001,000,0002,605,262Dec 07 04:14 PM
Broadfin Healthcare Master Fun10% OwnerNov 30Sale9.56168,4031,610,2172,705,262Nov 30 05:38 PM
Broadfin Healthcare Master Fun10% OwnerNov 29Sale9.676,66464,4322,873,665Nov 30 05:38 PM
Broadfin Healthcare Master Fun10% OwnerNov 28Sale9.6447,549458,4132,880,329Nov 30 05:38 PM
Broadfin Healthcare Master Fun10% OwnerNov 24Sale9.3718,114169,7352,927,878Nov 24 01:32 PM
Broadfin Healthcare Master Fun10% OwnerNov 22Sale9.3751,654483,9672,945,992Nov 24 01:32 PM
Broadfin Healthcare Master Fun10% OwnerNov 21Sale9.50102,440972,8632,997,646Nov 24 01:32 PM